These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 21085635)

  • 1. Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.
    Ensoli B; Bellino S; Tripiciano A; Longo O; Francavilla V; Marcotullio S; Cafaro A; Picconi O; Paniccia G; Scoglio A; Arancio A; Ariola C; Ruiz Alvarez MJ; Campagna M; Scaramuzzi D; Iori C; Esposito R; Mussini C; Ghinelli F; Sighinolfi L; Palamara G; Latini A; Angarano G; Ladisa N; Soscia F; Mercurio VS; Lazzarin A; Tambussi G; Visintini R; Mazzotta F; Di Pietro M; Galli M; Rusconi S; Carosi G; Torti C; Di Perri G; Bonora S; Ensoli F; Garaci E
    PLoS One; 2010 Nov; 5(11):e13540. PubMed ID: 21085635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.
    Ensoli F; Cafaro A; Casabianca A; Tripiciano A; Bellino S; Longo O; Francavilla V; Picconi O; Sgadari C; Moretti S; Cossut MR; Arancio A; Orlandi C; Sernicola L; Maggiorella MT; Paniccia G; Mussini C; Lazzarin A; Sighinolfi L; Palamara G; Gori A; Angarano G; Di Pietro M; Galli M; Mercurio VS; Castelli F; Di Perri G; Monini P; Magnani M; Garaci E; Ensoli B
    Retrovirology; 2015 Apr; 12():33. PubMed ID: 25924841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Tat immunity defines CD4
    Tripiciano A; Picconi O; Moretti S; Sgadari C; Cafaro A; Francavilla V; Arancio A; Paniccia G; Campagna M; Pavone-Cossut MR; Sighinolfi L; Latini A; Mercurio VS; Pietro MD; Castelli F; Saracino A; Mussini C; Perri GD; Galli M; Nozza S; Ensoli F; Monini P; Ensoli B
    EBioMedicine; 2021 Apr; 66():103306. PubMed ID: 33839064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.
    Sgadari C; Monini P; Tripiciano A; Picconi O; Casabianca A; Orlandi C; Moretti S; Francavilla V; Arancio A; Paniccia G; Campagna M; Bellino S; Meschiari M; Nozza S; Sighinolfi L; Latini A; Muscatello A; Saracino A; Di Pietro M; Galli M; Cafaro A; Magnani M; Ensoli F; Ensoli B
    Front Immunol; 2019; 10():233. PubMed ID: 30815001
    [No Abstract]   [Full Text] [Related]  

  • 6. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.
    Bellino S; Tripiciano A; Picconi O; Francavilla V; Longo O; Sgadari C; Paniccia G; Arancio A; Angarano G; Ladisa N; Lazzarin A; Tambussi G; Nozza S; Torti C; Focà E; Palamara G; Latini A; Sighinolfi L; Mazzotta F; Di Pietro M; Di Perri G; Bonora S; Mercurio VS; Mussini C; Gori A; Galli M; Monini P; Cafaro A; Ensoli F; Ensoli B
    Retrovirology; 2014 Jun; 11():49. PubMed ID: 24961156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination.
    Jost S; Tomezsko PJ; Rands K; Toth I; Lichterfeld M; Gandhi RT; Altfeld M
    J Virol; 2014 Aug; 88(15):8349-54. PubMed ID: 24829350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
    Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
    Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.
    Lévy Y; Lacabaratz C; Lhomme E; Wiedemann A; Bauduin C; Fenwick C; Foucat E; Surenaud M; Guillaumat L; Boilet V; Rieux V; Bouchaud O; Girard PM; Molina JM; Morlat P; Hocqueloux L; Richert L; Pantaleo G; Lelièvre JD; Thiébaut R
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O; Holub M; Spála J; Kalanin J; Stanková M
    Acta Virol; 2003; 47(2):121-4. PubMed ID: 14524479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV coinfection does not alter the frequency of regulatory T cells or CD8+ T cell immune activation in chronically infected HIV+ Chinese subjects.
    Zhuang Y; Wei X; Li Y; Zhao K; Zhang J; Kang W; Sun Y
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1044-51. PubMed ID: 22214236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.
    Rusconi S; Vitiello P; Adorni F; Colella E; Focà E; Capetti A; Meraviglia P; Abeli C; Bonora S; D'Annunzio M; Di Biagio A; Di Pietro M; Butini L; Orofino G; Colafigli M; d'Ettorre G; Francisci D; Parruti G; Soria A; Buonomini AR; Tommasi C; Mosti S; Bai F; Di Nardo Stuppino S; Morosi M; Montano M; Tau P; Merlini E; Marchetti G
    PLoS One; 2013; 8(11):e80157. PubMed ID: 24244635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.
    Lisziewicz J; Bakare N; Calarota SA; Bánhegyi D; Szlávik J; Ujhelyi E; Tőke ER; Molnár L; Lisziewicz Z; Autran B; Lori F
    PLoS One; 2012; 7(5):e35416. PubMed ID: 22590502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.
    Nicoli F; Finessi V; Sicurella M; Rizzotto L; Gallerani E; Destro F; Cafaro A; Marconi P; Caputo A; Ensoli B; Gavioli R
    PLoS One; 2013; 8(11):e77746. PubMed ID: 24223723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.
    Johnston AM; Valentine ME; Ottinger J; Baydo R; Gryszowka V; Vavro C; Weinhold K; St Clair M; McKinney RE
    Pediatr Infect Dis J; 2001 Oct; 20(10):941-6. PubMed ID: 11642627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.